Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)
Launched by MEDTRONIC - MITG · Dec 7, 2018
Trial Information
Current as of May 30, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The SODA clinical trial is designed to gather information and videos from a special device called the PillCam SB3, which helps doctors see inside the small intestine. This trial is focused on various conditions affecting the small intestine, including diseases, cancer, and bleeding. It is a simple observational study, meaning participants will be involved in a standard procedure where the PillCam is used, and their videos and data will be collected for future research.
Anyone who has an SB3 procedure as part of their regular medical care can join this trial, as long as they understand what the study is about and agree to participate. There are no specific exclusions, so many people may be eligible. Participants can expect their PillCam videos and reports to be recorded and stored, helping researchers learn more about small intestine health. This study is currently recruiting participants of all ages and genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All SB3 cases collected during standard of care procedures.
- • The subject received an explanation and understands the nature of the study and provided oral consenting
- Exclusion Criteria:
- • None
About Medtronic Mitg
Medtronic - Minimally Invasive Therapies Group (MITG) is a leading global sponsor focused on advancing minimally invasive surgical techniques and technologies to improve patient outcomes and optimize healthcare delivery. Committed to innovation and excellence, MITG develops a range of products and solutions that enhance surgical precision and efficiency, catering to a diverse array of medical conditions. Through rigorous clinical trials and research initiatives, Medtronic MITG aims to drive evidence-based practices in healthcare, ensuring that patients benefit from the latest advancements in minimally invasive procedures.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Kansas City, Kansas, United States
Philadelphia, Pennsylvania, United States
Birmingham, Alabama, United States
Kansas City, Missouri, United States
Columbus, Ohio, United States
Worcester, Massachusetts, United States
Cleveland, Ohio, United States
Columbia, Maryland, United States
Hamden, Connecticut, United States
Toledo, Ohio, United States
Chesterfield, Missouri, United States
Oklahoma City, Oklahoma, United States
Jacksonville, Florida, United States
Miami, Florida, United States
Atlanta, Georgia, United States
Morristown, New Jersey, United States
Brooklyn, New York, United States
Lake Success, New York, United States
New York, New York, United States
Chevy Chase, Maryland, United States
Escondido, California, United States
Farmington Hills, Michigan, United States
Albany, New York, United States
Summerville, South Carolina, United States
Austin, Texas, United States
Exton, Pennsylvania, United States
Valencia, California, United States
Pikesville, Maryland, United States
Miami, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials